topotecan has been researched along with nik 12192 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belfiore, P; Croce, AC; Dal Bo, L; Farina, C; Misiano, P; Petrangolini, G; Pratesi, G; Supino, R; Tortoreto, M; Zunino, F | 1 |
Bo, LD; Bottiroli, G; Casalini, P; Croce, AC; Farina, C; Favini, E; Misiano, P; Petrangolini, G; Pratesi, G; Radaelli, E; Supino, R; Tortoreto, M; Zunino, F | 1 |
2 other study(ies) available for topotecan and nik 12192
Article | Year |
---|---|
Effect of a novel vacuolar-H+-ATPase inhibitor on cell and tumor response to camptothecins.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzamides; Camptothecin; Enzyme Inhibitors; Female; HT29 Cells; Humans; Indoles; Irinotecan; Mice; Neoplasm Proteins; Neoplasms, Experimental; Staining and Labeling; Topotecan; Vacuolar Proton-Translocating ATPases | 2006 |
Antimetastatic effect of a small-molecule vacuolar H+-ATPase inhibitor in in vitro and in vivo preclinical studies.
Topics: Animals; Antineoplastic Agents; Benzamides; Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Cell Line, Tumor; Cell Movement; Female; Humans; Indoles; Integrin alphaVbeta3; Lung Neoplasms; Mice; Mice, Nude; Topotecan; Vacuolar Proton-Translocating ATPases; Wound Healing; Xenograft Model Antitumor Assays | 2008 |